ALC:NYSE
Alcon
63,76 $
arrow_downward
-0,28%(-0,18) 1D
63,76 $
0,00% (0,00)
bedtimeAfter hours
Closed: 2 հոկ, 16:00:09 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
64,39 $
High
64,42 $
Low
63,50 $
Mkt. cap
26,25 մլրդ
Avg. vol.
1,57 մլն
Volume
1,27 մլն
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,88
Shares outstanding
483,40 մլն
No. of employees
25 հզր
Open
64,39 $
High
64,42 $
Low
63,50 $
Mkt. cap
26,25 մլրդ
Avg. vol.
1,57 մլն
Volume
1,27 մլն
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,88
Shares outstanding
483,40 մլն
No. of employees
25 հզր
News stories
From web sources and news partners
AD HOC NEWS
·
13 ժամ առաջ
Jefferies cuts target for Alcon stock from USD 95.00 to USD 85.00
AD HOC NEWS
·
2 օր առաջ
Alcon stock after-hours at EUR 57.24: minus 0.68 percent versus prior close
AD HOC NEWS
·
2 օր առաջ
Alcon stock launches Systane PRO PF in Canada
Simply Wall St
·
2 օր առաջ
Did Dry Eye Drop Launch Just Shift Alcon's (SWX:ALC) Investment Narrative?
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon
CEODavid J. Endicott
Employees25 հզր
Founded1945
HeadquartersԺնև, Ժնև, Շվեյցարիա
Sector-
Websitealcon.com